How to Buy Vor Biopharma Stock

Vor Biopharma Inc

Vor Biopharma, Inc. , a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients.

Vor Biopharma stock last closed at $2.35, down 2.89% from the previous day, and has increased 142.27% in one year. It has overperformed other stocks in the Biotechnology industry by 2.12 percentage points. Vor Biopharma stock is currently +1,693.89% from its 52-week low of $0.13, and -28.57% from its 52-week high of $3.29.

At the moment, there are 124.96M VOR shares outstanding. The market capitalization of VOR is $293.65M. In the last 24 hours, 6.52M VOR shares were traded.

How to Buy Vor Biopharma Stock

Not sure how to invest in Vor Biopharma stock? Here's how.

  1. Figure out where to buy Vor Biopharma stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Vor Biopharma stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your investment account: Pick your method of payment and add your information.
  4. Analyze Vor Biopharma stock: The Vor Biopharma ticker symbol is VOR. Is Vor Biopharma stock a good investment? Should you buy shares of VOR? How do VOR's underlying business fundamentals look? Do top analysts think Vor Biopharma is a good buy? Why has VOR's stock price moved recently? (Hint: Our stock research website can help you evaluate if VOR is a good stock to buy).
  5. Place your VOR trade: Decide if you will purchase VOR shares at the current market price or use a limit order to purchase VOR stock at a particular price.
  6. Keep tabs on your VOR position: Create a watchlist to keep tabs on your investment in Vor Biopharma shares.

Step 1: Figure out where to buy Vor Biopharma stock

You will need a brokerage account to access the NASDAQ market and buy VOR stock.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to world markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the right brokerage, you need to fill out some personal info so you are able to buy VOR today.

How to Open a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal details to create your new brokerage account.
  1. Send your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have finished signing up on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:

Watch the walkthrough below if you need help transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Vor Biopharma stock

After you have figured out the best place to buy Vor Biopharma stock, it's important to analyze their stock before you buy, so you can wrap your head around the risk and upside.

Vor Biopharma quick stats

VOR Price
$2.35
1w %
14.63%
1y %
142.27%
5y %
N/A
P/E
-1.56x
P/B
4.44x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$118.60M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$293.65M
Next Earnings
Aug 7, 2025
Next Dividend
N/A

Vor Biopharma Due Diligence Score

WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on VOR's stock page.

What is the fair value of VOR stock?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge VOR's true value.

Using relative valuations measures:

  • VOR could be overvalued based on its P/B ratio of 4.44x, relative to Biotechnology industry P/B ratio of 4.42x

You can do additional valuation research on VOR's stock here.

VOR Financial Health Summary

Pros:

  • There are more short-term assets than long-term liabilities on the VOR balance sheet.
  • There are more short-term assets than short-term liabilities on the VOR balance sheet.

Cons:

  • VOR has a relatively high debt to equity ratio of 0.66.
  • VOR has cash burn of 100607000. It does not have enough cash and short-term investments to cover this.
  • VOR has $62.45M in cash and short term investments. This is not enough to cover its annual cash burn of $100.61M.

Is Vor Biopharma stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 6 Wall Street analysts who research VOR, the consensus analyst rating on Vor Biopharma is a Buy

Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.

Latest VOR Analyst Recommendations

Stephen Willey, a bottom 6% analyst from Stifel Nicolaus maintains VOR with a strong buy rating and lowers their VOR price target from $12.00 to $5.00, on Mar 21, 2025.

You can dig deeper into what analysts are forecasting on the Vor Biopharma stock forecast page.

VOR Momentum

SMA10
2.2
SMA20
2.19
SMA50
1.07
SMA100
0.87
SMA200
0.96
MACD
0.34
MACD Signal
0.39
MACD Histogram
-0.05
RSI
64.41
Stochastic %K
37.54
Stochastic %D
29.65
StochRSI %K
23.42
StochRSI %D
15.94

What are VOR executives and large shareholders up to?

Over the last year, executives and large shareholders at VOR have sold more shares than they have bought.

Robert Ang, PRESIDENT AND CEO of VOR, was the latest VOR insider to sell. They sold $1,322.16 worth of VOR stock on May 6, 2025.

Dig into more about who owns VOR stock here.

Does VOR stock generate passive income?

No, Vor Biopharma doesn't provide an income stream by paying out dividends.

What do other investors have to say about VOR?

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Place your VOR trade

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific dollar amount, place a limit order.

Click the Open Trade button and your broker will execute your order.

If you require more info about investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep tabs on your VOR position

Now that you own some VOR shares, you'll want to keep up with your new stock purchase.

Add VOR to a watchlist to get the latest updates about your VOR stock.

VOR Feed

How to Buy Stock in Vor Biopharma

To summarize, here are the 6 steps you need to take to buy Vor Biopharma stock right now:

  1. Figure out where to buy Vor Biopharma stock
  2. Create a brokerage account
  3. Fund your investment account
  4. Analyze Vor Biopharma stock
  5. Place your VOR trade
  6. Keep tabs on your VOR position

If you need a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your new investment in Vor Biopharma, create your watchlist below.

NASDAQ: VOR
$2.35-0.07 (-2.89%)
Updated Jul 29, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: VOR
$2.35-0.07 (-2.89%)
Updated Jul 29, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Vor Biopharma share?

As of Jul 29, 2025, it costs $2.35 to buy one share of Vor Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.426 shares of VOR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Vor Biopharma stock?

According to 6 Wall Street analysts who monitor Vor Biopharma, their consensus recommendation is to buy Vor Biopharma stock.

What is the best way to buy Vor Biopharma stock?

One way to place an order for Vor Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.